Skip to main content
20 April 2024
Last updated:
Thursday 18 April 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Strategy
Strategy
GLP-1 agonists shake up the sector
Read more
The quest for non-addictive chronic pain therapies
Read more
Treating hearing loss as people age
Read more
A regulatory win for a rare disease strategy
Read more
How private European MidPharmas sustain innovation
Read more
How Astex built a business on fragment-based discovery
Read more
GSK takes biological approach to malaria control
Read more
How pharma manages organisational complexity
Read more
European Biopharma doesn't skimp on R&D
Read more
Commentary: The analysis of biopharma R&D needs to be improved
Read more
Pagination
Page 1
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form